Printer Friendly

RESEARCH FRONTIERS' UNDERWRITER EXERCISES OVERALLOTMENT

 RESEARCH FRONTIERS' UNDERWRITER EXERCISES OVERALLOTMENT
 WOODBURY, N.Y., Jan. 30 /PRNewswire/ -- Research Frontiers Incorporated (NASDAQ: REFR) today announced that it had concluded the sale of 70,450 units, each unit consisting of one share of the company's common stock and one redeemable common stock purchase warrant, pursuant to the exercise by Paulson Investment Company, Inc. of the overallotment option granted to Paulson in connection with the company's recently concluded public offering of 625,000 units. The company received net proceeds of $467,611 from the exercise of the overallotment option, resulting in aggregate net proceeds of the public offering to the company of $4,538,695.
 -0- 1/30/92
 /CONTACT: Robert L. Saxe of Research Frontiers, 516-364-1902/
 (REFR) CO: Research Frontiers Incorporated ST: New York IN: SU: OFR


JT-TM -- NY054 -- 5205 01/30/92 11:36 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jan 30, 1992
Words:138
Previous Article:TREADCO, INC. ANNOUNCES 1991 OPERATING RESULTS AND FIRST QUARTER CASH DIVIDEND
Next Article:CONCEPT OMEGA CHANGES NAME TO THOROUGHBRED SOFTWARE INTERNATIONAL


Related Articles
PAGENET ANNOUNCES THE EXERCISE OF OVERALLOTMENT OPTION BY IPO UNDERWRITING GROUP
UNDERWRITERS' OPTION EXERCISED IN ARAMED UNIT OFFERING AND GENSIA COMMON STOCK OFFERING
O'BRIEN UNDERWRITERS EXERCISE OVERALLOTMENT OPTION TO PURCHASE 585,300 SHARES
O'BRIEN UNDERWRITERS EXERCISE OVERALLOTMENT OPTION TO PURCHASE 585,300 SHARES
SOMATIX RAISES ADDITIONAL $5.2 MILLION: OVERALLOTMENT OPTION EXERCISED
MID AM, INC. EXERCISES OVERALLOTMENT OPTION
NUCORP UNDERWRITERS EXERCISE OVERALLOTMENT OPTION
Telvent GIT, S.A. Completes Partial Exercise of Overallotment Option.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters